PHPer Steinar Halvorsen

Per Steinar Halvorsen

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Per Steinar Halvorsen has a total of 67 co-authors. Here are the top co-authors by number of shared publications:

  • Erik Fosse

    The Intervention Centre, Rikshospitalet, Oslo University Hospital, Oslo, Norway

    4 shared publications
  • Helge Skulstad

    Department of Cardiology, Rikshospitalet, Oslo University Hospital, Oslo, Norway

    4 shared publications
  • Andreas Espinoza

    The Intervention Centre, Oslo University Hospital, Oslo, Norway

    3 shared publications
  • Harald Arne Bergan

    Department of Anaesthesiology, Oslo University Hospital, Oslo, Norway

    3 shared publications
  • Jan Frederik Bugge

    From the Division of Emergencies and Critical Care, Department of Anesthesiology, Oslo University Hospital, Rikshospitalet (JFB, VK, HCN, PSH), Faculty of Medicine, Institute of Clinical Medicine, University of Oslo (VK) and Division of Emergencies and Critical Care, The Intervention Centre, Oslo University Hospital, Rikshospitalet, Oslo, Norway (PSH)

    3 shared publications
  • Andreas Espinoza

    The Intervention Centre, Division of Technology and Innovation, Oslo University Hospital, Oslo, Norway

    2 shared publications

Latest Publications

  • Open Access

    The effect of ventilation methods on liver movement during general anesthesia for thermal ablation of liver tumors

    by Karina Roheim Lappen, Ingrid Schrøder Hansen, Ida Björk, Daniel Østergaard, Per Steinar Halvorsen, Hilde Lang Orrem, Åsmund Avdem Fretland, Trygve Syversveen, Andreas Espinoza

    Purpose: Precise needle placement is vital for effective thermal ablation of liver tumors. Ventilation during anesthesia induces liver movement. This study compares different ventilation strategies and their impact on the movement of right and left inferior liver margins. Materials: We conducted a non-randomized crossover study involving 20 patients scheduled for thermal ablation of liver metastases from colon cancer (November 2022–April 2024). Methods: Five ventilation modes were evaluated: standard ventilation; low-tidal-volume, high-frequency ventilation; one-lung ventilation; and high-frequency jet ventilation with and without additional normal-frequency jet ventilation. Movement of the inferior liver margins was measured using ultrasound, recording cranio-caudal displacement of the left lobe at the midline and the right lobe at the anterior axillary line. Results: Standard ventilation resulted in the greatest movement with 5.8 mm of the left and 7.3 mm of the right inferior liver margin. Low-tidal-volume, high-frequency ventilation reduced movement to 4.0 mm on the left and 4.6 mm on the right side. High-frequency jet ventilation caused the least movement, with 1.2 mm of the left and 0.5 mm of the right margin, the latter comparable to right-sided one-lung ventilation, which caused movement of the right margin of 1.6 mm. Conclusion: Liver movement varied by ventilation method. High-frequency jet ventilation and right-sided one-lung ventilation provided the greatest stabilization, low-tidal-volume, high-frequency ventilation reduced movement compared with standard ventilation, and standard ventilation produced the largest movement. These differences may help guide the choice of ventilation strategy in procedures sensitive to organ motion. Trial registration: Clinicaltrials.gov ID, NCT05129787 , registered 11/02/2021.


  • Open Access

    Monitoring stroke volume continuously and autonomously using an epicardial accelerometer

    by Vetle Christoffer Frostelid, Lars-Egil R. Hammersboen, Manuel Villegas-Martinez, Fred-Johan Pettersen, Ole Jakob Elle, Per Steinar Halvorsen, Espen W. Remme

  • Open Access

    Non-invasive Waveform Analysis for Emergency Triage via Simulated Hemorrhage: An Experimental Study using Novel Dynamic Lower Body Negative Pressure Model

    by Naimahmed Nesaragi, Lars Øivind Høiseth, Hemin Ali Qadir, Leiv Arne Rosseland, Per Steinar Halvorsen, Ilangko Balasingham

    The extent to which advanced waveform analysis of non-invasive physiological signals can diagnose levels of hypovolemia remains insufficiently explored. The present study explores the discriminative ability of a deep learning (DL) framework to classify levels of ongoing hypovolemia, simulated via novel dynamic lower body negative pressure (LBNP) model among healthy volunteers. We used a dynamic LBNP protocol as opposed to the traditional model, where LBNP is applied in a predictable step-wise, progressively descending manner. This dynamic LBNP version assists in circumventing the problem posed in terms of time dependency, as in real-life pre-hospital settings, intravascular blood volume may fluctuate due to volume resuscitation. A supervised DL-based framework for ternary classification was realized by segmenting the underlying noninvasive signal and labeling segments with corresponding LBNP target levels. The proposed DL model with two inputs was trained with respective time-frequency representations extracted on waveform segments to classify each of them into blood volume loss: Class 1 (mild); Class 2 (moderate); or Class 3 (severe). At the outset, the latent space derived at the end of the DL model via late fusion among both inputs assists in enhanced classification performance. When evaluated in a 3-fold cross-validation setup with stratified subjects, the experimental findings demonstrated PPG to be a potential surrogate for variations in blood volume with average classification performance, AUROC: 0.8861, AUPRC: 0.8141, $F1$-score:72.16%, Sensitivity:79.06 %, and Specificity:89.21 %. Our proposed DL algorithm on PPG signal demonstrates the possibility of capturing the complex interplay in physiological responses related to both bleeding and fluid resuscitation using this challenging LBNP setup.

  • Improved Detection Of Thromboembolic Complications In Left Ventricular Assist Device By Novel Accelerometer-Based Analysis

    by Itai Schalit, Andreas Espinoza, Fred-Johan Pettersen, Helge Skulstad, Erik Fosse, Arnt E. Fiane, Per S. Halvorsen

    We have previously demonstrated that accelerometer-based vibration analysis detects thromboembolism and pump thrombosis in HeartWare Left Ventricular Assist Device (HVAD) using the third harmonic frequency (pump_speedx3). Thromboembolism also affected the amplitude of the nonharmonic frequencies. The aim of this study was to determine whether nonharmonic-amplitude (NHA) analysis can improve the diagnosis of thromboembolic complications. An accelerometer was attached to HVAD in three in vitro and seven in vivo experiments. Control interventions, including load and pump speed alternations (n = 107), were followed by thromboembolic events (n = 60). A sliding fast-Fourier-transform was analyzed, and changes in NHAs were quantified in the acute phase and in a steady state. Receiver operating characteristic curves were constructed with cutoff values of NHA to detect thromboembolic events. Positive predictive values were calculated on the basis of a specificity of 1. In the acute phase, NHA change was 6.5 times higher under thromboembolism than under control interventions (p < 0.001). Most thromboembolic events lead to concomitant changes in both NHA and third-harmonic amplitude. Combining the two methods improved the PPV by 8.3%. At steady state, signal changes predominantly demonstrated either NHA or third-harmonic changes. Combined signal analysis improved the PPV by 36%. This method enhanced the detection of thromboembolism and pump thrombosis in the HVAD.


  • Open Access

    Esmolol for cardioprotection during resuscitation with adrenaline in an ischaemic porcine cardiac arrest model

    by Hilde Karlsen, Harald Arne Bergan, Per Steinar Halvorsen, Kjetil Sunde, Eirik Qvigstad, Geir Øystein Andersen, Jan Frederik Bugge, Theresa Mariero Olasveengen

    Background: The effectiveness of adrenaline during resuscitation continues to be debated despite being recommended in international guidelines. There is evidence that the β-adrenergic receptor (AR) effects of adrenaline are harmful due to increased myocardial oxygen consumption, post-defibrillation ventricular arrhythmias and increased severity of post-arrest myocardial dysfunction. Esmolol may counteract these unfavourable β-AR effects and thus preserve post-arrest myocardial function. We evaluated whether a single dose of esmolol administered prior to adrenaline preserves post-arrest cardiac output among successfully resuscitated animals in a novel, ischaemic cardiac arrest porcine model. Methods: Myocardial infarction was induced in 20 anaesthetized pigs by inflating a percutaneous coronary intervention (PCI) balloon in the circumflex artery 15 min prior to induction of ventricular fibrillation. After 10 min of untreated VF, resuscitation with veno-arterial extracorporeal membrane oxygenation (VA-ECMO) was initiated and the animals were randomized to receive an injection of either 1 mg/kg esmolol or 9 mg/ml NaCl, prior to adrenaline. Investigators were blinded to allocation. Successful defibrillation was followed by a 1-h high-flow VA-ECMO before weaning and an additional 1-h stabilization period. The PCI-balloon was deflated 40 min after inflation. Cardiac function pre- and post-arrest (including cardiac output) was assessed by magnetic resonance imaging (MRI) and invasive pressure measurements. Myocardial injury was estimated with MRI, triphenyl tetrazolium chloride (TTC) staining and serum concentrations of cardiac troponin T. Results: Only seven esmolol and five placebo-treated pigs were successfully resuscitated and available for post-arrest measurements ( p = 0.7). MRI revealed severe but similar reductions in post-arrest cardiac function with cardiac output 3.5 (3.3, 3.7) and 3.3 (3.2, 3.9) l/min for esmolol and control (placebo) groups, respectively ( p = 0.7). The control group had larger left ventricular end-systolic and end-diastolic ventricular volumes compared to the esmolol group (75 (65, 100) vs. 62 (53, 70) ml, p = 0.03 and 103 (86, 124) vs. 87 (72, 91) ml, p = 0.03 for control and esmolol groups, respectively). There were no other significant differences in MRI characteristics, myocardial infarct size or other haemodynamic measurements between the two groups. Conclusions: We observed similar post-arrest cardiac output with and without a single dose of esmolol prior to adrenaline administration during low-flow VA-ECMO in an ischaemic cardiac arrest pig model.


  • Open Access

    Corrigendum to ‘Left ventricular function can be continuously monitored with an epicardially attached accelerometer sensor’ [Eur J Cardiothorac Surg 2014;46:313–20]†

    by Stefan Hyler, Andreas Espinoza, Helge Skulstad, Erik Fosse, Per Steinar Halvorsen

    It was unfortunately not mentioned in the methods section that the data presented were obtained from an animal series performed by the same research group: Halvorsen PS, Fleischer LA, Espinoza A, Elle OJ, Hoff L, Skulstad H, Edvardsen T, Fosse E. Detection of myocardial ischaemia by epicardial accelerometers in the pig. Br J Anaesth 2009;102(1):29-37; doi: 10.1093/bja/aen331. Other data from the 2009 animal series were included in a combined experimental and clinical publication in 2010; Halvorsen PS, Remme EW, Espinoza A, Skulstad H, Lundblad R, Bergsland J, Hoff L, Imenes K, Edvardsen T, Elle OJ, Fosse E. Automatic real-time detection of myocardial ischemia by epicardial accelerometer. J Thorac Cardiovasc Surg 2010;139(4):1026-32; doi: 10.1016/j.jtcvs.2009.05.031.

  • Open Access

    Does therapeutic hypothermia during extracorporeal cardiopulmonary resuscitation preserve cardiac function?

    by Harald A. Bergan, Per S. Halvorsen, Helge Skulstad, Erik Fosse, Jan F. Bugge

    Background: Extracorporeal cardiopulmonary resuscitation (E-CPR) is increasingly used as a rescue method in the management of cardiac arrest and provides the opportunity to rapidly induce therapeutic hypothermia. The survival after a cardiac arrest is related to post-arrest cardiac function, and the application of therapeutic hypothermia post-arrest is hypothesized to improve cardiac outcome. The present animal study compares normothermic and hypothermic E-CPR considering resuscitation success, post-arrest left ventricular function and magnitude of myocardial injury. Methods: After a 15-min untreated ventricular fibrillation, the pigs (n = 20) were randomized to either normothermic (38 °C) or hypothermic (32–33 °C) E-CPR. Defibrillation terminated ventricular fibrillation after 5 min of E-CPR, and extracorporeal support continued for 2 h, followed by warming, weaning and a stabilization period. Magnetic resonance imaging and left ventricle pressure measurements were used to assess left ventricular function pre-arrest and 5 h post-arrest. Myocardial injury was estimated by serum concentrations of cardiac TroponinT and Aspartate transaminase (ASAT). Results: E-CPR resuscitated all animals and the hypothermic strategy induced therapeutic hypothermia within minutes without impairment of the resuscitation success rate. All animals suffered a severe global systolic left ventricular dysfunction post-arrest with 50–70% reductions in stroke volume, ejection fraction, wall thickening, strain and mitral annular plane systolic excursion. Serum concentrations of cardiac TroponinT and ASAT increased considerably post-arrest. No significant differences were found between the two groups. Conclusions: Two-hour therapeutic hypothermia during E-CPR offers an equal resuscitation success rate, but does not preserve the post-arrest cardiac function nor reduce the magnitude of myocardial injury, compared to normothermic E-CPR. Trial registration FOTS 4611/13 registered 25 October 2012


  • An Implantable Accelerometer-Based Heart-Monitoring Device With Improved Positional Stability

    by Fjodors Tjulkins, Anh-Tuan Thai Nguyen, Erik Andreassen, Lars Hoff, Ole-Johannes Grymyr, Per Steinar Halvorsen, Kristin Imenes

    This paper reports recent results from an ongoing effort to develop an implantable accelerometer-based heart-monitoring device for ischemia monitoring. The latest device prototype utilizes a new and more compact accelerometer (1.2 × 1.5 × 0.8 mm3), a prototype device from Bosch SensorTec, Reutlingen, Germany. This paper presents the fabrication and testing of the device, including an explorative study of the effect of the capsule shape on the stability of the implanted device in the heart tissue. The stability study indicated sufficient stability of the device and a higher resistance to retraction for one of the capsule designs. The device was able to carry out acceleration monitoring and it meets the leakage current requirements of the IEC60601 standard.


  • Open Access

    Long-term outcomes after transcatheter aortic valve implantation: the impact of intraoperative tissue Doppler echocardiography

    by Jo Eidet, Gry Dahle, Jan F. Bugge, Bjørn Bendz, Kjell A. Rein, Lars Aaberge, Jon T. Offstad, Erik Fosse, Svend Aakhus, Per S. Halvorsen

    Transcatheter aortic valve implantation improves survival in patients with severe aortic stenosis who are ineligible for surgical valve replacement; however, not all patients benefit from the procedure. We endeavoured to identify these patients using intraoperative echocardiography and hypothesized that intraoperative left ventricular function in response to the acute afterload reduction during the procedure was related to long-term outcomes. We prospectively included 64 patients who were scheduled for transcatheter aortic valve implantation and divided them into responders and non-responders based on their left ventricular intraoperative responses to the acute afterload reduction after valve deployment. Responders were defined by increases of ≥20% in left ventricular longitudinal peak systolic velocities determined by tissue Doppler echocardiography. All patients were assessed for the following outcomes at 12 months: cardiac mortality, adverse cardiac events, quality of life, New York Heart Association class, N-terminal pro-brain natriuretic peptide (NT-proBNP) and echocardiography. Thirty-five patients (55%) were classified as responders and 29 patients (45%) as non-responders. Compared with responders, non-responders had higher risks of death (28 vs 9%, respectively, P = 0.04) and cardiac events (66 vs 26%, respectively, P < 0.01) during the 12-month follow-up. Significant long-term improvements in quality of life, NT-proBNP and left ventricular function were observed only in the responders. Preoperative risk stratification, intraoperative handling, aortic gradient and valve area were similar between groups. Intraoperative assessment of left ventricular function by tissue Doppler echocardiography predicted long-term outcomes after transcatheter aortic valve implantation. Our results suggest that a preoperative test of myocardial contractile reserve might improve risk stratification and patient selection prior to the procedure.


  • Intraoperative improvement in left ventricular peak systolic velocity predicts better short-term outcome after transcatheter aortic valve implantation

    by Jo Eidet, Gry Dahle, Jan Frederik Bugge, Bjørn Bendz, Kjell Arne Rein, Lars Aaberge, Jon Thomas Offstad, Erik Fosse, Svend Aakhus, Per Steinar Halvorsen

    OBJECTIVES Left ventricular function is expected to improve after transcatheter aortic valve implantation due to the acute reduction in afterload, but does not occur in all patients. We hypothesized that the immediate intraoperative response in systolic left ventricular longitudinal motion during the procedure could be a predictor of short-term outcome. METHODS Sixty-four patients treated with transcatheter aortic valve implantation for severe aortic stenosis were included. Transoesophageal 4- and 2-chamber echocardiograms were obtained immediately prior to and ∼15 min after valve implantation. Patients were defined as responders if their average left ventricular longitudinal peak systolic velocity increased by ≥20% from the preimplantation value and was related to the 3-month outcome. RESULTS Thirty-five patients were classified as responders, with an increase in the intraoperative longitudinal peak systolic velocity from an average of 2.2 ± 0.8 to 3.1 ± 1.1 cm/s (P < 0.001); the velocity was unchanged in the remaining 29 patients, who averaged 2.4 ± 1.1 cm/s. There were significantly fewer adverse cardiac events in the responder group at the 3-month follow-up (20 vs 45%, P = 0.03) and the New York Heart Association class was significantly better in the responders compared with non-responders. Responders had a significant reduction in N-terminal probrain natriuretic peptide levels [243 (113–361) vs 163 (64–273), P = 0.004] at the 3-month follow-up, whereas non-responders did not [469 (130–858) vs 289 (157–921), P = 0.48]. CONCLUSIONS An immediate improvement in the longitudinal peak systolic velocity during the transcatheter aortic valve implantation procedure predicted a better short-term outcome and may be useful in identifying patients who are at risk of a less favourable outcome after transcatheter aortic valve implantation.